Search research articles
Contact Us
Filters
Showing results (1-10 of 174) with videos related to
Page
of 18
Sort By:
Trends in Biotechnology
|
January 9, 2001
Cataloguing life
K Ashman
Trends in Biotechnology
|
February 17, 2001
A Babelfish for biology
K Ashman
Immunology and Cell Biology
|
August 1, 1987
The immunogenicity of tumour cells
L K Ashman
The International Journal of Biochemistry & Cell Biology
|
December 3, 1999
The biology of stem cell factor and its receptor C-kit
L K Ashman
Molecular Cancer Therapeutics
|
November 11, 2011
Cell line models identify different sensitivity of mutant forms of c-KIT to kinase inhibitory drugs and predict the response of patients to therapy
Leonie K Ashman
Oncogene
|
March 12, 2013
Renal disease as a potential compounding factor in carcinogenesis experiments with Cd151-null mice
L K Ashman
Journal of Biological Regulators and Homeostatic Agents
|
November 29, 2002
CD151
L K Ashman
The Australian Journal of Experimental Biology and Medical Science
|
August 1, 1983
Stimulatory ability of human leukaemic cells in the allogeneic mixed leucocyte reaction
L K Ashman
Cellular Immunology
|
September 1, 1984
Proliferative response of normal and activated human lymphocytes to tetradecanoyl phorbol acetate
L K Ashman
Biological Chemistry Hoppe-Seyler
|
July 1, 1986
A new covalently modified support for gas-liquid phase sequencing
R Frank, K Ashman
Page
of 18
Search research articles
Search
Showing results (1-10 of 174) with videos related to
Sort By:
Page
of 18
Trends in Biotechnology
|
January 9, 2001
Cataloguing life
K Ashman
Trends in Biotechnology
|
February 17, 2001
A Babelfish for biology
K Ashman
Immunology and Cell Biology
|
August 1, 1987
The immunogenicity of tumour cells
L K Ashman
The International Journal of Biochemistry & Cell Biology
|
December 3, 1999
The biology of stem cell factor and its receptor C-kit
L K Ashman
Molecular Cancer Therapeutics
|
November 11, 2011
Cell line models identify different sensitivity of mutant forms of c-KIT to kinase inhibitory drugs and predict the response of patients to therapy
Leonie K Ashman
Oncogene
|
March 12, 2013
Renal disease as a potential compounding factor in carcinogenesis experiments with Cd151-null mice
L K Ashman
Journal of Biological Regulators and Homeostatic Agents
|
November 29, 2002
CD151
L K Ashman
The Australian Journal of Experimental Biology and Medical Science
|
August 1, 1983
Stimulatory ability of human leukaemic cells in the allogeneic mixed leucocyte reaction
L K Ashman
Cellular Immunology
|
September 1, 1984
Proliferative response of normal and activated human lymphocytes to tetradecanoyl phorbol acetate
L K Ashman
Biological Chemistry Hoppe-Seyler
|
July 1, 1986
A new covalently modified support for gas-liquid phase sequencing
R Frank, K Ashman
Page
of 18